TY  - GEN
AU  - Bielack,S S
AU  - Cox,M C
AU  - Nathrath,M
AU  - Apel,K
AU  - Blattmann,C
AU  - Holl,T
AU  - Jenewein,R
AU  - Klenk,U
AU  - Klothaki,P
AU  - Müller-Abt,P
AU  - Ortega-Lawerenz,S
AU  - Reynolds,M
AU  - Scheer,M
AU  - Simon-Klingenstein,K
AU  - Stegmaier,S
AU  - Tupper,R
AU  - Vokuhl,C
AU  - von Kalle,T
TI  - Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
SN  - 1569-8041
PY  - 2020///0911
KW  - Drug Resistance, Neoplasm
KW  - Fibrosarcoma
KW  - drug therapy
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Male
KW  - Neoplasm Recurrence, Local
KW  - Oncogene Proteins, Fusion
KW  - genetics
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Salvage Therapy
N1  - Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdz382
ER  -